ICF Macro Inc.
ICF Macro Inc. is a subsidiary of ICF International, Inc., specializing in providing professional services and technology solutions to federal agencies. The company excels in survey research, data collection and analysis, program evaluation, technical assistance, communication campaigns, and training. ICF Macro supports a wide range of federal initiatives in public health, substance abuse prevention, social services, international development, and environmental protection. Through its federal contract and grant awards, the company delivers expertise in areas such as health information systems, behavioral risk factor surveillance, tobacco cessation, HIV/AIDS research, and universal health coverage.
ICF Macro has secured numerous prime federal contract awards across multiple agencies. For the Centers for Disease Control and Prevention (CDC), the company has provided services ranging from health communications and drug overdose prevention campaigns to diabetes health marketing and occupational safety research. The National Science Foundation has contracted ICF Macro for survey support on topics like federal facilities R&D and science and engineering workforce studies. The Internal Revenue Service has utilized ICF Macro's expertise for taxpayer experience surveys and small business research. Other notable contracts include work for the Department of Labor on international labor affairs, the National Highway Traffic Safety Administration for traffic safety research, and the Department of Veterans Affairs for COVID-19 impact studies. Many of these contracts were awarded without set-aside designations, leveraging existing contract vehicles such as the GSA Multiple Award Schedule and agency-specific Blanket Purchase Agreements.
In the realm of federal grants, ICF Macro has participated as both a prime recipient and subrecipient. As a prime, the company received a grant from the National Institute of Mental Health to develop methods for assessing youth suicide prevention programs in small, high-risk communities. As a subrecipient, ICF Macro has supported a wide array of projects. These include conducting Behavioral Risk Factor Surveillance System (BRFSS) surveys for multiple state health departments, assisting with the National Alcohol Survey for the Public Health Institute, and providing technical support for USAID-funded health systems strengthening initiatives in countries like Togo and Cote d'Ivoire. The company has also contributed to HIV/AIDS research through the PEPFAR-supported Population-based HIV Impact Assessment (PHIA) surveys in various countries, working under the University of Maryland, Baltimore.
ICF Macro holds several significant Indefinite Delivery Vehicles (IDVs) that allow for streamlined task order awards from federal agencies. Under the Safe Healthcare, Epidemiology, and Prevention Research Development Program (SHEPheRD) IDV awarded by the CDC, ICF Macro can provide research and technical support services related to healthcare-associated infections and adverse drug events, with a potential value of $99 million over five years. The company also holds a Blanket Purchase Agreement with the Internal Revenue Service for customer research services, valued at $10 million through 2026. Additionally, ICF Macro is part of the Health Resources and Services Administration's (HRSA) Evaluation Studies IDV, which facilitates the production of focused, high-priority evaluation activities for HRSA's bureaus and offices, with a ceiling value of $50 million through 2024. These IDVs demonstrate ICF Macro's capacity to provide comprehensive research, evaluation, and technical assistance services across multiple health and human services domains.
DQ7YZMCK5D23 541611
Not listed 1902 Reston Metro Plaza, Reston, VA 20190, USA
7/30/01 3/18/25 Westat, Inc.
Westat, Inc. is a prominent professional services firm that provides a wide range of research, technical assistance, and program support services to various federal agencies. Established in 1963 and headquartered in Rockville, Maryland, Westat specializes in survey research, data collection and analysis, program evaluation, and information technology solutions. The company has extensive experience working with government entities, particularly in areas such as public health, education, transportation, and social policy. Westat's federal contract and grant awards span numerous agencies, including the Department of Health and Human Services, Department of Education, National Science Foundation, and Department of Transportation, among others.
Through its federal contract awards, Westat has provided diverse services across multiple domains. For the National Cancer Institute, Westat has supported cancer clinical trials, offering services such as site study setup, protocol writing, and electronic patient-reported outcomes collection. The company has conducted national surveys for agencies like the National Highway Traffic Safety Administration, including occupant protection use surveys and booster seat usage studies. Westat has also provided data collection and analysis services for the Centers for Disease Control and Prevention, supporting programs such as the National Immunization Surveys. For the Food and Drug Administration, Westat has conducted studies on consumer perceptions of food labeling and medical device recalls. The company has also supported the Environmental Protection Agency with statistical analysis and technical support for various environmental health studies. These contracts demonstrate Westat's capabilities in large-scale data collection, analysis, and program evaluation across various public health and safety domains.
Westat's federal grant awards further showcase its expertise in research and evaluation services. The company has received grants from the National Institute of Justice to design and implement studies on interpersonal violence among young adults. For the National Institutes of Health, Westat has supported HIV/AIDS clinical trial networks and studies on maternal and child health. The company has also assisted the Bureau of Justice Statistics in conducting surveys on jails in Indian Country. Westat has collaborated with universities and research institutions on grants focused on topics such as sleep disparities, cognitive health, and substance abuse prevention. Additionally, the company has supported international health initiatives, such as population-based HIV impact assessment surveys in various countries. These grant-funded projects demonstrate Westat's ability to conduct complex, multi-year research studies and provide specialized data collection and analysis services in support of public health and social science research.
Westat holds several significant Indefinite Delivery Vehicles (IDVs) with federal agencies, allowing for the issuance of task orders across a range of services. The company has a $320 million IDV with the National Cancer Institute for field and biospecimen support services, which includes study management, exposure assessment, and clinical support for cancer research. Westat also holds a $548 million IDV for the Cancer Trials Support Unit, providing broad-based support for cancer clinical trials. The Centers for Disease Control and Prevention awarded Westat a $310 million IDV for the National Immunization Surveys program, supporting vaccination coverage monitoring efforts. The company has a $175 million IDV with the National Institute of Child Health and Human Development for international and domestic pediatric HIV studies. Additionally, Westat holds IDVs with agencies such as the Substance Abuse and Mental Health Services Administration, the Administration for Community Living, and the Institute of Education Sciences, covering areas such as behavioral health research, aging and disability services, and education program evaluations. These IDVs demonstrate Westat's capacity to provide comprehensive, long-term support across various federal research and program evaluation initiatives.
NVUWAFWQ57S5 541720
Not listed 1600 Research Blvd, Rockville, MD 20850, USA
9/5/01 1/9/26 The Trustees Of Columbia University In The City Of New York
The Trustees of Columbia University in the City of New York, doing business as the Health Sciences Division, is a private university and non-profit organization that provides a wide range of products and services to the federal government through contracts and grant awards. Columbia University is one of the leading research institutions in the country, with extensive experience conducting biomedical research, providing healthcare services, offering technical assistance, delivering training, and performing program evaluations across public health, medicine, and education domains.
Through federal contract awards from agencies like the Department of Health and Human Services, Department of Defense, and Centers for Disease Control and Prevention, Columbia University has provided services related to clinical immunization safety assessment, HIV and tuberculosis program implementation support, laboratory systems strengthening, and development of antisense therapeutics for rare forms of amyotrophic lateral sclerosis (ALS). These contracts often involve collaborations with prime contractors and subcontractors like the Washington University, Mayo Clinic, New York University, and private companies like Blackrock and Synapticure Inc. Some contracts have been set aside for specific designations like small businesses or institutions serving underrepresented communities.
On the grant side, Columbia University has received funding from agencies including the National Institutes of Health, Centers for Disease Control and Prevention, Department of Defense, and National Endowment for the Humanities. Grant awards span a diverse range of biomedical research areas like Alzheimer's disease, cancer, infectious diseases, neurological disorders, maternal and child health, and substance abuse. Programs supported include basic laboratory research, clinical trials, epidemiological studies, genomic sequencing projects, public health surveillance, intervention development, and community engagement efforts. Many grants involve collaborations with other academic institutions, healthcare providers, community organizations, and industry partners as prime or sub-recipients.
Columbia University holds a $86 million indefinite delivery contract from the Centers for Disease Control and Prevention to provide clinical immunization safety assessment services through 2028. A $305K delivery order has already been awarded against this IDV. As the leading public health agency, the CDC partners with research institutions like Columbia University to continuously monitor and ensure the safety of vaccines as part of disease prevention efforts.
QHF5ZZ114M72 611310
Not listed 630 W 168th St, New York, NY 10032, USA
5/13/03 10/8/25